MAPK3 and colorectal cancer: TMEM176A may have different functions in various tumor types; studies have shown that indicates that it can trigger apoptotic cell death and inhibit their migration and invasion in colorectal cancer cells [59], while other research suggests that it acts as a tumor promoter in glioblastoma cells, potentially promoting progression through ERK1/2 phosphorylation [57].